CDTX stock · KO stock

CDTX vs KO

Cidara Therapeutics Inc (CDTX) versus The Coca-Cola Company (KO) — a side-by-side from cached financials, not a winner call.

Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.

The Coca-Cola Company (KO) is a beverages - non-alcoholic company listed on NYSE. It is led by James Quincey.

Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.

Latest reported KO revenue for 2025-12-31 was $47.94B. Net income was $13.11B. Revenue was up 1.9% from 2024-12-31 to 2025-12-31. KO currently screens at market cap $343.90B and trailing P/E 25.1.

CDTX currently screens at market cap $6.96B. KO currently screens at market cap $343.90B and trailing P/E 25.1.

Not investment advice. Open the CDTX and KO stock pages for the full models.

Not investment advice.

Popular Stock Comparisons